UK medtech company making AI-powered soft robotic wearables, including the Lifeglov glove, for stroke and neurological rehabilitation.
Bioliberty is a medical technology company that develops AI-powered soft robotic wearables and software for physical and occupational therapy, initially targeting hand and upper-limb rehabilitation after stroke and other neurological conditions.
Its core products are Lifeglov, a pneumatically actuated soft robotic glove that assists patients in opening and closing the hand, and Lifehub, the control system and software platform that runs therapy sessions, tracks patient progress and powers the commercial "Lifehub Clinic" package sold to rehabilitation facilities. Lifeglov and Lifehub were FDA-registered in December 2024, supporting the company's US commercial launch in 2025.
Bioliberty was founded in 2020 by University of Edinburgh graduates Rowan Armstrong, Ross O'Hanlon, Conan Bradley and Shéa Quinn, and is based at the National Robotarium in Edinburgh with a US office in Boston and manufacturing in Fife, Scotland. The company has raised Series A funding from investors including the Scottish National Investment Bank, Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC, Conduit Connect, TGH Ventures (the investment arm of Tampa General Hospital), Ballad Ventures, Whiterock and 25m Health.